Table 8.

The inhibition rate of tumor growth in each group after injection (%).

GroupTumor inhibition rate
131I-IgG (IT, 150 μCi)16.81 ± 48.77**
131I-rituximab (IT, 75 μCi)17.91 ± 18.96**
131I-rituximab (IT, 150 μCi)55.03 ± 9.94**
131I-rituximab (IP, 150 μCi)5.53 ± 17.72*
Control56.01 ± 95.36

  • Compared with control cell group

  • ↵* P<0.05

  • ↵* P<0.01.